Anna M J Thijs et al.
Hypertension (Dallas, Tex. : 1979), 61(5), 1060-1065 (2013-03-20)
Angiogenesis inhibitors have remarkably improved the outcome of patients with several types of cancer. Hypertension is the most reported side effect of angiogenesis inhibitors interfering with vascular endothelial growth factor signaling. In this study, we test the hypothesis that circulating